Under construction – not a live service
Sign in
Taking people in IsraelNo phase

Studies the Medtronic 780G system in children and youth with type 1 diabetes

Observes young people with type 1 diabetes using the Medtronic 780G insulin system.

Plain-language title generated from the registry record
Registry title: Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

Key facts

Where
Ramat Gan, IsraelSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 1 and 21 years old?

Source: NCT05908708, who can take part

Where in Israel

  • Sheba medical centerRamat Gan, IsraelTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sheba Medical Center
Trial code
NCT05908708
Record updated
9 April 2026
Original description
The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.Read full original descriptionShow less

Title: Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes: AWeSoMe Study Group Prospective Trial

The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.

Inclusion: Diagnosis of type 1 diabetes Diabetes duration ≥ 6 months Routine attendance at clinic visits Initiation of 780G system usage.

Exclusion: Children under the age of 1 year Children without 780G system.

ClinicalTrials.gov NCT05908708